Scientific progress depends on the expertise, reagents and technologies behind every experiment. We are Fortis Life Sciences Where science finds momentum. Fortis was established in 2020 to create a more unified and scalable approach to supporting modern research and development. Together, Fortis companies provide capabilities across - antibodies - diagnostic components - viral vector platforms - molecular biology reagents - engineered nanoparticles - lyophilization - manufacturing so you can work with greater continuity across complex scientific workflows. Work that once required multiple suppliers can now move forward with one partner: stronger technical alignment, a more stable supply chain, and support across discovery, translational research, and advanced biologics development.
Boston
2020
201–500
